Biobank for Inflammatory Chronic Diseases and Osteoporosis

Sponsor
University Hospital, Toulouse
Study ID
NCT05039216
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 99 Years
Healthy Volunteers
Not accepted

Interventions

  • Blood sampling — BIOLOGICAL
    4 tubes of 7 mL will be sampled

Study Details

The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.

Key Dates

First listed
Sep 9, 2021
Start date
Sep 13, 2021
Status verified
Mar 2026
Primary completion
Sep 2, 2026
Completion
Sep 1, 2031

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: patients initiating a biotherapy or a target treatment
    Blood sampling
  • Arm: patients with chronic inflammatory rheumatism, weakening osteopathy or mechanical pathology
    Blood sampling

Primary Outcome Measure

EULAR response after 3 months [ Time Frame: after 3 months ]

Central Contacts

Find similar trials

Nationwide
Psoriatic arthritis trialsRheumatoid arthritis trialsRheumatology trialsAutoimmune disease trialsMusculoskeletal disorders trials

Related Studies